These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32782736)

  • 1. Crosstalk between Sleep Disturbance and Opioid Use Disorder: A Narrative Review.
    Fathi HR; Yoonessi A; Khatibi A; Rezaeitalab F; Rezaei-Ardani A
    Addict Health; 2020 Apr; 12(2):140-158. PubMed ID: 32782736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adults with Comorbid Posttraumatic Stress Disorder, Alcohol Use Disorder, and Opioid Use Disorder: The Effectiveness of Modified Prolonged Exposure.
    Peck KR; Schumacher JA; Stasiewicz PR; Coffey SF
    J Trauma Stress; 2018 Jun; 31(3):373-382. PubMed ID: 29786898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional Relationship between Opioids and Disrupted Sleep: Putative Mechanisms.
    Eacret D; Veasey SC; Blendy JA
    Mol Pharmacol; 2020 Oct; 98(4):445-453. PubMed ID: 32198209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid Therapy and Sleep Disorders: Risks and Mitigation Strategies.
    Cheatle MD; Webster LR
    Pain Med; 2015 Oct; 16 Suppl 1(0 1):S22-6. PubMed ID: 26461072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study).
    Nordmann S; Lions C; Vilotitch A; Michel L; Mora M; Spire B; Maradan G; Morel A; Roux P; Carrieri MP;
    Psychopharmacology (Berl); 2016 Apr; 233(7):1203-13. PubMed ID: 26753792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Glitch in the Matrix: The Role of Extracellular Matrix Remodeling in Opioid Use Disorder.
    Ray MH; Williams BR; Kuppe MK; Bryant CD; Logan RW
    Front Integr Neurosci; 2022; 16():899637. PubMed ID: 35757099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysomnographic sleep disturbances in nicotine, caffeine, alcohol, cocaine, opioid, and cannabis use: A focused review.
    Garcia AN; Salloum IM
    Am J Addict; 2015 Oct; 24(7):590-8. PubMed ID: 26346395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep disturbances in treatment-seeking OCD-patients: Changes after concentrated exposure treatment.
    Nordahl H; Havnen A; Hansen B; Öst LG; Kvale G
    Scand J Psychol; 2018 Apr; 59(2):186-191. PubMed ID: 29244201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of buprenorphine/naloxone maintenance treatment on sexual dysfunction, sleep and weight in opioid use disorder patients.
    Baykara S; Alban K
    Psychiatry Res; 2019 Feb; 272():450-453. PubMed ID: 30611963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
    Dunn KE; Finan PH; Andrew Tompkins D; Strain EC
    Addict Behav; 2018 Jan; 76():8-14. PubMed ID: 28735039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of sleep disturbances related to substance use disorders].
    Vetrova MV; Rybakova KV; Goncharov OV; Kuchmenko DN; Genina IN; Semenova NV; Makarov IV; Zubova EY; Neznanov NG; Krupitsky EM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(5):153-159. PubMed ID: 32621482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of opioid analgesics or sleeping medication and survival of cancer patients.
    Chang WP; Lin CC
    Eur J Oncol Nurs; 2015 Jun; 19(3):199-206. PubMed ID: 25553718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The failing cascade: Comorbid post traumatic stress- and opioid use disorders.
    Elman I; Borsook D
    Neurosci Biobehav Rev; 2019 Aug; 103():374-383. PubMed ID: 31063739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine.
    Malcolm BJ; Polanco M; Barsuglia JP
    J Psychoactive Drugs; 2018; 50(3):256-265. PubMed ID: 29608409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain, opioids, and sleep: implications for restless legs syndrome treatment.
    Trenkwalder C; Zieglgänsberger W; Ahmedzai SH; Högl B
    Sleep Med; 2017 Mar; 31():78-85. PubMed ID: 27964861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A narrative review: The effects of opioids on sleep disordered breathing in chronic pain patients and methadone maintained patients.
    Hassamal S; Miotto K; Wang T; Saxon AJ
    Am J Addict; 2016 Sep; 25(6):452-65. PubMed ID: 27554389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids in headache treatment. Is there a role?
    Ziegler DK
    Neurol Clin; 1997 Feb; 15(1):199-207. PubMed ID: 9058406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid tapering in patients with prescription opioid use disorder: A retrospective study.
    Zhou K; Jia P; Bhargava S; Zhang Y; Reza T; Peng YB; Wang GG
    Scand J Pain; 2017 Oct; 17():167-173. PubMed ID: 28988103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nexus of opioids, pain, and addiction: Challenges and solutions.
    Henningfield JE; Ashworth JB; Gerlach KK; Simone B; Schnoll SH
    Prev Med; 2019 Nov; 128():105852. PubMed ID: 31634511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.